Ftse Mib
33.843,83
1,08%
DAX
20.016,75
0,55%
S&P 500
6.044,05
-0,05%
NASDAQ
19.426,00
0,11%
Bitcoin
95.362,32
-0,52%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hutchmed (china) Limited (HCM) Hutchmed (china) Limited (HCM) Notizie

HCM

Hutchmed (china) (HCM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HCM
DataOraFonteTitoloSimboloCompagnia
03/12/202413:19Alliance NewsAlliance NewsHutchmed China injection approval could be a "paradigm shift"LSE:HCMHutchmed (china) Limited
03/12/202411:00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and Innovent Announce ELUNATE ApprovalLSE:HCMHutchmed (china) Limited
29/11/202409:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
28/11/202411:32RNS Non-RegulatoryHutchmed (China) Limited Continued Inclusion of ORPATHYS in China NRDLLSE:HCMHutchmed (china) Limited
22/11/202411:00Alliance NewsAlliance NewsHutchmed to get payment from Takeda as Fruzaqla launched in JapanLSE:HCMHutchmed (china) Limited
22/11/202408:00RNS Non-RegulatoryHutchmed (China) Limited FRUZAQLA® Launched in Japan by TakedaLSE:HCMHutchmed (china) Limited
20/11/202410:30RNS Regulatory NewsHutchmed (China) Limited Appointment of Independent Non-executive DirectorLSE:HCMHutchmed (china) Limited
06/11/202408:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASH and ESMO AsiaLSE:HCMHutchmed (china) Limited
31/10/202413:02Alliance NewsAlliance NewsHutchmed China receives first milestone payment for Takeda drug salesLSE:HCMHutchmed (china) Limited
31/10/202409:30RNS Non-RegulatoryHutchmed (China) Limited First Commercial Milestone PaymentLSE:HCMHutchmed (china) Limited
21/10/202410:30RNS Regulatory NewsHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
16/10/202410:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:HCMHutchmed (china) Limited
16/10/202408:00RNS Regulatory NewsHutchmed (China) Limited SAVANNAH: clinically meaningful response rateLSE:HCMHutchmed (china) Limited
24/09/202409:49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:HCMHutchmed (china) Limited
24/09/202409:00RNS Regulatory NewsHutchmed (China) Limited Japan Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
09/09/202408:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO and WCLCLSE:HCMHutchmed (china) Limited
30/08/202413:24Alliance NewsAlliance NewsHutchmed "disappointed" as it withdraws fruquintinib applicationLSE:HCMHutchmed (china) Limited
30/08/202408:00RNS Regulatory NewsHutchmed (China) Limited Update on Fruquintinib for Gastric Cancer in ChinaLSE:HCMHutchmed (china) Limited
22/08/202410:30RNS Regulatory NewsHutchmed (China) Limited Standard form for notification of major holdingsLSE:HCMHutchmed (china) Limited
21/08/202410:30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Host Expert Call to discuss ITPLSE:HCMHutchmed (china) Limited
06/08/202411:00RNS Regulatory NewsHutchmed (China) Limited LTIP and Share Option SchemeLSE:HCMHutchmed (china) Limited
31/07/202415:41Alliance NewsAlliance NewsHutchmed confident of full year guidance for oncology and immunologyLSE:HCMHutchmed (china) Limited
31/07/202413:00RNS Regulatory NewsHutchmed (China) Limited 2024 Interim Results and Business UpdatesLSE:HCMHutchmed (china) Limited
05/07/202420:08Alliance NewsAlliance NewsIN BRIEF: Hutchmed's tazemetostat given priority review in ChinaLSE:HCMHutchmed (china) Limited
04/07/202408:00RNS Non-RegulatoryHutchmed (China) Limited NDA Acceptance in China for TazemetostatLSE:HCMHutchmed (china) Limited
28/06/202413:35RNS Non-RegulatoryHutchmed (China) Limited Overseas Regulatory Announcement: Form F-3 FilingLSE:HCMHutchmed (china) Limited
28/06/202410:30RNS Regulatory NewsHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
26/06/202410:30RNS Regulatory NewsHutchmed (China) Limited HUTCHMED to Announce 2024 HY Financial ResultsLSE:HCMHutchmed (china) Limited
24/06/202411:30RNS Non-RegulatoryHutchmed (China) Limited Save the Date: HUTCHMED to Present R&D UpdatesLSE:HCMHutchmed (china) Limited
24/06/202411:00Alliance NewsAlliance NewsIN BRIEF: Hutchmed China notes Takeda obtains EU approval for FruzaqlaLSE:HCMHutchmed (china) Limited
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HCM

La tua Cronologia

NASDAQ
ARTNA
Artesian Resources
NASDAQ
SJW
SJW
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network